p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Cell Biology

• Publication date

  2009-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncb1875PMID 19448627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 in health and disease

  2007cited by this paper
• Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down‐regulation of E‐cadherin

  2007cited by this paper
• The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.

  2007cited by this paper
• The oncogenic roles of p53 mutants in mouse models.

  2007cited by this paper
• Loss of p53 and Ink4a/Arf cooperate in a cell autonomous fashion to induce metastasis of hepatocellular carcinoma cells.

  2007cited by this paper
• Clonality and Prognostic Implications of p53 and Epidermal Growth Factor Receptor Somatic Aberrations in Multiple Primary Lung Cancers

  2007cited by this paper
• Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

  2006cited by this paper
• Tumor metastasis: mechanistic insights and clinical challenges

  2006cited by this paper
• Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts.

  2006cited by this paper
• Complex networks orchestrate epithelial–mesenchymal transitions

  2006cited by this paper
• Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients

  2006cited by this paper
• Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa

  2006cited by this paper
• The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma

  2005cited by this paper
• Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer

  2005cited by this paper
• Transcription Repressor Slug Promotes Carcinoma Invasion and Predicts Outcome of Patients with Lung Adenocarcinoma

  2005cited by this paper
• The melanocyte differentiation program predisposes to metastasis after neoplastic transformation

  2005cited by this paper
• SLUG in cancer development

  2005cited by this paper
• Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma.

  2005cited by this paper
• Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.

  2005cited by this paper
• Aberrant Expression of the Transcription Factors Snail and Slug Alters the Response to Genotoxic Stress

  2004cited by this paper
• Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

  2004cited by this paper
• Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.

  2004cited by this paper
• The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors

  2003cited by this paper
• Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.

  2003cited by this paper
• The p53-Mdm2 module and the ubiquitin system.

  2003cited by this paper
• Clinical, cellular, and molecular aspects of cancer invasion.

  2003cited by this paper
• p53 and apoptosis: it's not just in the nucleus anymore.

  2003cited by this paper
• Requirement of the Co-repressor Homeodomain-interacting Protein Kinase 2 for Ski-mediated Inhibition of Bone Morphogenetic Protein-induced Transcriptional Activation*

  2003cited by this paper
• The snail superfamily of zinc-finger transcription factors

  2002cited by this paper
• The SLUG zinc-finger protein represses E-cadherin in breast cancer.

  2002cited by this paper
• Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.

  2002cited by this paper
• High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

  2002cited by this paper
• Assessing TP53 status in human tumours to evaluate clinical outcome

  2001cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

  2000cited by this paper
• Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements

  1999cited by this paper
• Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility

  1999cited by this paper
• A causal role for E-cadherin in the transition from adenoma to carcinoma

  1998cited by this paper
• Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas

  1997cited by this paper
• Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line.

  1997cited by this paper
• Revisions in the International System for Staging Lung Cancer.

  1997cited by this paper
• Expression pattern of the cell adhesion molecules. E-cadherin, P-cadherin and alpha 6 beta 4 intergrin is altered in pre-malignant skin tumors of p53-deficient mice.

  1996cited by this paper
• Expression pattern of the cell adhesion molecules E‐cadherin, P‐cadherin and α6β4 integrin is altered in pre‐malignant skin tumors of p53‐deficient mice

  1996cited by this paper
• Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.

  1995cited by this paper
• Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

  1994cited by this paper
• E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

  1991cited by this paper

• Regulatory mechanisms for Snail protein stability: ubiquitin-proteasome system and chaperone-mediated autophagy.

  2026cites this paper
• Maternally Expressed Gene 3 (MEG3) LncRNA: The Silent Guardian Against Solid and Hematological Malignancies.

  2026cites this paper
• A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer.

  2025cites this paper
• A Novel Inhibitor of Methyltransferase SMYD2, AZ505 Protects Against Peritoneal Fibrosis in Mice

  2025cites this paper
• Bypassing the guardian: regulated cell death pathways in p53-mutant cancers

  2025cites this paper
• PiRNAs, PiRNA‐Like, and PIWI Proteins in Somatic Cells: From Genetic Regulation to Disease Mechanisms

  2025cites this paper
• 白花蛇舌草可逆转大鼠胃癌前病变胃黏膜上皮-间充质转化

  2025cites this paper
• Targeting the MCM10/p53/p21/CCND1 Axis in Colorectal Cancer: Evaluating the Therapeutic Potential of Ultrasound.

  2025cites this paper
• Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis

  2025cites this paper
• Tumor suppressors in Sox2-mediated lung cancers promote distinct cell-intrinsic and immunologic remodeling

  2025cites this paper
• Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators

  2025cites this paper
• Gain of function p53 mutant R273H confers distinct methylation profiles and consequent YAP/TAZ signaling mediated activation of partial or full EMT states to colon tumours

  2025cites this paper
• Correlation of P53 expression and epithelial-mesenchymal transition in non-small cell lung cancer.

  2025cites this paper
• The Patterns of P53, E-Cadherin, β-Catenin, CXCR4 and Podoplanin Expression in Oral Squamous Cell Carcinoma Suggests a Hybrid Invasion Model: an Immunohistochemical Study on Tissue Microarrays

  2025cites this paper
• Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies

  2025cites this paper
• Mutant p53: evolving perspectives

  2025cites this paper
• Multi-omics approaches including single-cell analysis and machine learning were used to identify the roles of telomere-related genes in esophageal squamous cell carcinoma

  2025cites this paper
• GNPNAT1 Serves as a Prognostic Biomarker Correlated with Immune Infiltration and Promotes Cancer Cell Metastasis through Stabilization of Snai2 in Lung Adenocarcinoma

  2024cites this paper
• Impact of RBMS 3 Progression on Expression of EMT Markers

  2024cites this paper
• Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer

  2024cites this paper
• Matrix Metalloproteinase 11 Promotes Migration and Invasion of Colorectal Cancer by Elevating Slug Protein

  2024cites this paper
• Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review

  2024cites this paper
• Unlocking the potential of LHPP: Inhibiting glioma growth and cell cycle via the MDM2/p53 pathway.

  2024cites this paper
• Targeting mutant p53: a key player in breast cancer pathogenesis and beyond

  2024cites this paper
• The Scribble/SGEF/Dlg1 complex regulates E-cadherin and ZO-1 stability, turnover, and transcription in epithelial cells.

  2024cites this paper
• A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT.

  2024cites this paper
• Epstein-Barr Virus BARF1 Is Expressed in Lung Cancer and Is Associated with Cancer Progression

  2024cites this paper
• The Scribble/SGEF/Dlg1 complex regulates the stability of apical junctions in epithelial cells

  2024cites this paper
• Systematic review and meta-analysis of relationship between p53 protein expression and lymph node metastasis, vascular invasion, and perineural invasion in pancreatic cancer

  2024cites this paper
• Modeling metastatic progression from cross-sectional cancer genomics data

  2024influential citation
• Identification of SOX9-related prognostic DEGs and a prediction model for hepatitis C-induced early-stage fibrosis.

  2024cites this paper
• Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response

  2024cites this paper
• EVA1A reverses lenvatinib resistance in hepatocellular carcinoma through regulating PI3K/AKT/p53 signaling axis

  2024cites this paper
• ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.

  2024cites this paper
• Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma

  2023cites this paper
• Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe.

  2023cites this paper
• FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation

  2023cites this paper
• Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy.

  2023cites this paper
• CircFSCN1 induces tumor progression and triggers epithelial-mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing.

  2023cites this paper
• TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2

  2023cites this paper
• Epithelial–mesenchymal transition: an organizing principle of mammalian regeneration

  2023cites this paper
• USP13 promotes breast cancer metastasis through FBXL14-induced Twist1 ubiquitination

  2023cites this paper
• Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR.

  2023cites this paper
• Targeting p53 pathways: mechanisms, structures and advances in therapy

  2023cites this paper
• Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression

  2023cites this paper
• TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors

  2023cites this paper
• Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants

  2023cites this paper
• p53 regulates the effects of DAPT on Rac1 activation and migration of non-small-cell lung cancer cells

  2023cites this paper
• Tp53 haploinsufficiency is involved in hotspot mutations and cytoskeletal remodeling in gefitinib-induced drug-resistant EGFRL858R-lung cancer mice

  2023cites this paper
• Functional role and epithelial to mesenchymal transition of the miR-590-3p/MDM2 axis in hepatocellular carcinoma

  2023cites this paper
• CopA3 peptide inhibits MDM2-p53 complex stability in colorectal cancers and activates p53 mediated cell death machinery.

  2023cites this paper
• USP7 imparts partial EMT state in colorectal cancer by stabilizing the RNA helicase DDX3X and augmenting Wnt/β-catenin signaling.

  2023cites this paper
• CCT8 promotes cell migration and tumor metastasis in lung adenocarcinomas

  2023cites this paper
• p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act

  2023cites this paper
• GMI, a Ganoderma microsporum protein, abolishes focal adhesion network to reduce cell migration and metastasis of lung cancer.

  2023cites this paper
• Biochemical characterization and anti-cancer activity of tangential flow filtration system assisted purification of fucoglucan from Laminaria japonica.

  2022cites this paper
• Downregulation of MDM2 by small interference RNA induces apoptosis and sensitizes MCF‐7 breast cells to resveratrol

  2022cites this paper
• Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies

  2022cites this paper
• Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy.

  2022cites this paper
• CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial–mesenchymal transition via inhibiting MDM2

  2022cites this paper
• The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response.

  2022cites this paper
• Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex.

  2022cites this paper
• Involvement of the p53/p21 complex in p53-dependent gene expression.

  2022cites this paper
• LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells

  2022cites this paper
• Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition

  2022influential citation
• GMI, Ganoderma microsporum protein, suppresses cell mobility and increases temozolomide sensitivity through induction of Slug degradation in glioblastoma multiforme cells.

  2022cites this paper
• SNAIL driven by a feed forward loop motif promotes TGFβ induced epithelial to mesenchymal transition

  2022cites this paper
• The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer

  2022cites this paper
• Estradiol-mediated inhibition of DNMT1 decreases p53 expression to induce M2-macrophage polarization in lung cancer progression

  2022cites this paper
• The study of cancer cell in stromal environment through induced pluripotent stem cell–derived mesenchymal stem cells

  2022cites this paper
• Epidemiology of Glioblastoma Multiforme–Literature Review

  2022cites this paper
• From start to finish—a molecular link in wound repair

  2022cites this paper
• Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?

  2022cites this paper
• Activation of CD44 signaling in leader cells induced by tumor-associated macrophages drives collective detachment in luminal breast carcinomas

  2022cites this paper
• Ubiquitination and deubiquitination in the regulation of epithelial-mesenchymal transition in cancer: Shifting gears at the molecular level.

  2022cites this paper
• AXL-TBK1 driven nuclear AKT3 promotes metastasis

  2022cites this paper
• It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy

  2022cites this paper
• Cigarette Smoke Impairs Airway Epithelial Wound Repair: Role of Modulation of Epithelial-Mesenchymal Transition Processes and Notch-1 Signaling

  2022cites this paper
• Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.

  2022cites this paper
• Slug promotes p53 and p21 protein degradation by inducing Mdm2 expression in HCT116 colon cancer cells

  2021cites this paper
• Arginine methylation in the epithelial‐to‐mesenchymal transition

  2021cites this paper
• p53 and Tumor Suppression: It Takes a Network.

  2021cites this paper
• Targeting Oncoimmune Drivers of Cancer Metastasis

  2021cites this paper
• GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer

  2021cites this paper
• Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma

  2021cites this paper
• AS1411-functionalized delivery nanosystems for targeted cancer therapy

  2021cites this paper
• MicroRNA‑10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells.

  2021cites this paper
• MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3

  2021cites this paper
• Research progress of EMT in Cancer Metastasis

  2021cites this paper
• TP53 Mutation and Extraneural Metastasis of Glioblastoma

  2021cites this paper
• YY1 and tumor metastasis regulation

  2021cites this paper
• Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.

  2021cites this paper
• Guardian of genome on the tract: wild type p53-mdm2 complex inhibition in healing the breast cancer.

  2021cites this paper
• Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies

  2021cites this paper
• Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.

  2021cites this paper
• The Post-Translational Regulation of Epithelial–Mesenchymal Transition-Inducing Transcription Factors in Cancer Metastasis

  2021influential citation
• BMP9 Can Induce Schwann Cells Expressing Simian Virus 40 T Antigen to Differentiate into Fat and Bone In Vivo and In Vitro

  2021cites this paper
• KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Breast Cancer and the Other Non-Coding RNAs

  2021cites this paper
• MicroRNA-140-3p alleviates intervertebral disc degeneration via KLF5/N-cadherin/MDM2/Slug axis

  2021cites this paper